Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

World News

Brazilian leader Lula released from hospital after suffering vertigo

by admin May 27, 2025
May 27, 2025
Brazilian leader Lula released from hospital after suffering vertigo

Brazil’s President Luiz Inácio Lula da Silva was diagnosed with labyrinthitis Monday after suffering from vertigo, hospital officials said.

The 79-year-old leftist leader has already returned to the country’s presidential residence, where he is resting.

The Sirio-Libanes Hospital said in a statement that Lula underwent imaging and blood tests, and its results came within normal limits. Labyrinthitis is an inflammation of the labyrinth in the inner ear, which is responsible for hearing and balance.

The health scare adds to Lula’s recent medical worries, which are also part of his allies’ concerns ahead of his likely bid for reelection next year.

The most serious is a fall he had in the bathroom of the presidential residence in Brasília on Oct. 19.

Almost two months later, he was transferred to São Paulo for surgery after suffering headaches caused by new a bleeding in his head.

He was discharged Dec. 15.

This post appeared first on cnn.com

previous post
Hong Kong’s baby pandas finally get names. Meet Jia Jia and De De
next post
Phase 1 Drill Program – Operational and Geological Progress Update

Related Posts

Mark Carney and the backlash against backlash politics

March 16, 2025

Man caring for ancestors’ grave may have ignited...

March 31, 2025

El Salvador arrests human rights lawyer critical of...

May 20, 2025

Trump’s two-week delay on Iran strike decision leaves...

June 21, 2025

Ukraine’s mineral riches have long been eyed by...

February 5, 2025

Orbital rocket crashes seconds after take-off in rare...

March 31, 2025

What did King Charles say in his letter...

March 1, 2025

Multiple French prisons attacked in response to government’s...

April 16, 2025

‘It feels like a missile is following me’:...

June 20, 2025

Oświęcim’s sole Jewish resident reflects on modern antisemitism...

January 26, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 6

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved